DEA Rescheduling Makes CBD Stocks Blazing Hot

HENDERSON, NV / ACCESSWIRE / October 2, 2018 / The DEA has just made a move that makes that has investors fired up.Last week, U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.

The agency announced Thursday that drugs including "finished dosage formulations" of CBD with THC below 0.1% will be considered Schedule 5 drugs, as long as the medications have been approved by the U.S. Food and Drug Administration.

It is the first time the agency has removed any type of cannabis from Schedule 1.

This has made CBD stocks even hotter than they have been.CBD stallwarts like GW Pharma, who was a large reason for this ruling are obviously benefitting, however, for investors looking to maximize their profit potential from this ruling it's beneficial to dig a little deeper.

That's why we're highlighting ChineseInvestors.com, Inc. (CIIX) a premier Chinese company with a couple CBD subsidiaries that has started to generate some impressive revenue.The company just released their fiscal 2018 results, and they were impressive.A 41% increase over 2017 buoyed by a 28,859% increase in consumer product sales largely attributed to their CBD lines.

We're not the only ones who like CIIX, SeeThru Equity just released a report with a $3.75 price target.From their recent $0.80 close that would represent a gain of over 400% price increase!

Now is the perfect time to act on this under the radar gem.

CBD stocks to watch include: ChineseInvestors.com, Inc. (CIIX), GW Pharmaceuticals, Inc. (GWPH), CannTrust Holdings, Inc. (CNTTF), India Globalization Capital, Inc. (IGC), and New Age Beverages, Inc. (NBEV).

ChineseInvestors.com, Inc. (CIIX)

Market Cap: $25.23M Share Price: $0.72

ChineseInvestors.com, Inc. (CIIX), a leading online financial information provider for Chinese investors, announced plans to launch CBD Hemp Wine, its private brand, hemp-infused, rice wine, through its wholly-owned foreign enterprise CBD Biotechnology Co. Ltd ("CBD Biotech"). Given the popularity of infused wine and liquor in recent years, CBD Biotech's new hemp-infused, rice wine was developed with the hemp enthusiast in mind. Moreover, CBD Biotech believes that there are potential long-term, functional benefits of hemp and rice wine. In Bama, a Chinese village located in Guangxi Province, the famed "longevity town of China" known for having the longest living residents, the villagers claim to have discovered the secret of long life: rice wine, which they drink throughout the day, snake wine, and a soup made from hemp seeds. Bama is also one of the world's five longevity towns in terms of distribution rate of centenarians, with a population of just over 300,000, 73 of whom are centenarians, one of the highest ratios in the world. This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

GW Pharmaceuticals, Inc. (GWPH)

Market Cap: $4.81B Share Price: $170.75

GW Pharmaceuticals plc, is a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. The company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Its lead product is Epidiolex, an oral medicine which is in Phase III clinical development for the treatment of efractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis.

CannTrust Holdings, Inc. (OTC PINK: CNTTF)

Market Cap: $1.02B Share Price: $9.76

CannTrust Holdings Inc., one of Canada's leading licensed producers and trusted brands of medical cannabis, announced the appointment of Peter Aceto as Chief Executive Officer of CannTrust, effective immediately. Eric Paul, CannTrust's Co-Founder and leader, has stepped down from his role as Chief Executive Officer, and has been named Chairman of the Board and Special Advisor to CannTrust's management team. Mark Litwin is assuming the role of Vice Chairman.

India Globalization Capital, Inc. (NYSE American: IGC)

Market Cap: $461.47M Share Price: $5.09

IGC announced that it has executed a distribution and partnership agreement for several products including a sugar free, energy drink called 'Nitro G'. IGC plans to create a branded, hemp/CBD-infused version of the formulation that addresses market demand for energy drinks with the inclusion of healthy properties derived from hemp including CBD.

New Age Beverages Corporation (NBEV)

Market Cap: $353.19M Share Price: $7.14

NBEV announced that it would be debuting a new portfolio of cannabidiol-infused beverages at the upcoming North American Convenience Show in Las Vegas from October 7th to the 10th. The stock nearly quadrupled in the week ending on Sep 21, only to shed a third of its value last week at Thursday's close and rallied again on Friday. The company will be meeting with some of the major retailers in the country at NACS and will be taking orders on a first come, first serve basis, given anticipated demand.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two.ACR Communication, LLC has been compensated one thousand dollars cash for this article and tweleve thousand dollars total by Regal Consulting. LLC, for news commentary articles for CIIX.CIIX and Regal Consulting, LLC were given an opportunity to edit information included in this article.This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information.We may buy or sell additional shares of CIIX in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

For Full Legal Disclaimer Click Here.

Regal Consulting, LLC, For Full Legal Disclaimer Click Here.

Contact Information:

Company Name: Microcap Speculators

Contact Person: Media Manager

Email: info@microcapspecualtors.com

Phone: 1-702-720-6310

Country: United States

Website: http://microcapspeculators.com/

SOURCE: ACR Communication, LLC